Growth monitoring still has a place in selected populations of children
- PMID: 22700067
- PMCID: PMC3070317
- DOI: 10.1136/bcr.01.2010.2640
Growth monitoring still has a place in selected populations of children
Abstract
In 1998, a multiprofessional group developed a consensus on growth monitoring in the UK. While routine serial measurements were not recommended in healthy children, it is clear that there is a subset of children at increased risk of growth-modifying disease who may benefit from growth monitoring. This subset includes children with genetic disorders at increased risk of thyroid dysfunction. Symptoms and signs of thyroid dysfunction are non-specific in the early stages of disease and are easily mistaken for features of an underlying genetic disorder. In this article, we report the case of a 2.8-year-old girl with 18q deletion syndrome who was profoundly weak, hypotonic and poorly responsive at diagnosis of Grave's disease. She was tall and her bone age was 2 years advanced, indicating long-standing disease. Growth monitoring of this patient should have enabled earlier diagnosis and avoided a serious and potentially fatal episode.
Conflict of interest statement
Figures
References
-
- Cody JD, Ghidoni PD, DuPont BR, et al. Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet 1999;85:455–62 - PubMed
-
- Schaub RL, Hale DE, Rose SR, et al. The spectrum of thyroid abnormalities in individuals with 18q deletions. J Clin Endocrinol Metab 2005;90:2259–63 - PubMed
-
- Tutunculer F, Darendeliler F, Gunoz H, et al. 18q deletion syndrome associated with autoimmune thyroid disease presenting as hyperthyroidism. J Pediatr Endocrinol Metab 2005;18:419–20 - PubMed
-
- Hale DE, Cody JD, Baillargeon J, et al. The spectrum of growth abnormalities in children with 18q deletions. J Clin Endocrinol Metab 2000;85:4450–4 - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources